Breaking News Instant updates and real-time market news.

CELG

Celgene

$98.50

-2.13 (-2.12%)

19:19
10/16/16
10/16
19:19
10/16/16
19:19

Celgene reports Phase 1b data on GED-0301 in Crohn's disease

Celgene announced that data from a phase 1b study evaluating the effects of investigational oral GED-0301, or mongersen, on both endoscopic response and clinical remission in patients with active Crohn's disease will be presented at the United European Gastroenterology Week. A total of 63 patients were enrolled in the study. The population was more diverse than prior GED-0301 studies and included patients with endoscopically confirmed mucosal damage at entry and those who had previous surgeries. Results showed that clinical improvement was seen by week 2, and clinical response and remission rates were highest in the 12-week treatment group at 67 and 48 percent respectively, at week 12. The mean CDAI reduction from baseline at week 12 in the 12-week treatment group was 133 points. Of the patients with evaluable endoscopies at week 12, 37 percent had an endoscopic response, with no meaningful difference across treatment groups. In addition, of those patients with greater endoscopic disease activity at baseline, 63 percent exhibited a reduction greater than or equal to 25 percent in SES-CD score and 31 percent had a reduction of greater than or equal to 50 percent. The rates of adverse events and serious adverse events were low and similar across treatment groups. There were no new safety signals for oral GED-0301 160 mg daily reported in this study.

  • 27

    Oct

  • 06

    Nov

CELG Celgene
$98.50

-2.13 (-2.12%)

10/14/16
ADAM
10/14/16
NO CHANGE
Target $156
ADAM
Buy
Celgene pipeline broader and stronger than ever, says Canaccord
Canaccord analyst John Newman said Celgene's pipeline is broader and stronger than at any point in its history.He reiterated his Buy rating based on his confidence in the commercial potential for GED-0301 for Crohn's disease, ozanimod in both ulcerative colitis and multiple sclerosis, and continued growth for Otezla. Newman reiterated his $156 price target on Celgene shares.
09/30/16
PIPR
09/30/16
NO CHANGE
Target $25
PIPR
Overweight
Piper's Schimmer found Nektar validation at Celgene event
Piper Jaffray analyst Joshua Schimmer says Celgene's (CELG) analyst event provided "another indirect validation" of Nektar Therapeutics' (NKTR) oncology approach. Celgene surprisingly implicated IL-2 as one of the primary mechanisms of Revlimid, Schimmer tells investors in a research note. He views the development as supporting his "enthusiastic outlook" for NKTR-214, the company's long-acting IL-2 targeting Teffector cells. The analyst reiterates an Overweight rating on Nektar with a $25 price target.
09/29/16
SBSH
09/29/16
NO CHANGE
Target $127
SBSH
Buy
Citi ups Celgene target to $127 on luspatercept opportunity
Citi analyst Robyn Karnauskas raised her price target for Celgene (CELG) to $127 from $124 citing greater confidence in the company's myelodysplastic syndrome and beta thalassemia opportunities. After initiating coverage of Celgene partner Acceleron (XLRN) with a Neutral rating, Karnauskas now sees adjusted peak sales for these indications of $1.7B versus $825M previously. Investors are missing the "not-so-distant catalyst" as Phase 3 luspatercept data in these indications could come in late 2017/early 2018, the analyst tells investors in a research note. She keeps a Buy rating on shares of Celgene.
09/16/16
RBCM
09/16/16
NO CHANGE
RBCM
Celgene shares can advance, says RBC Capital
RBC Capital analyst Michael Yee says that Celgene's stock "can grind higher" as investors eventually understand that the company's GED-0301 drug could potentially generate $1B in revenue. Yee says endoscopy data the company is expected to present next month on GED-0301 "isn't likely to be impressive." However, he thinks the data will "suggest that the drug is working," and he says that investor expectations are low, while the recent pullback in the shares has created an attractive entry point.

TODAY'S FREE FLY STORIES

12:50
12/06/16
12/06
12:50
12/06/16
12:50
General news
Euro$ interest rate futures are marginally lower »

Euro$ interest rate…

OMC

Omnicom

$86.97

0.92 (1.07%)

, IPG

Interpublic Group

$24.03

0.03 (0.13%)

12:49
12/06/16
12/06
12:49
12/06/16
12:49
Hot Stocks
Omnicom, Interpublic Group drop following WSJ headline »

Shares of Omnicom (OMC),…

OMC

Omnicom

$86.97

0.92 (1.07%)

IPG

Interpublic Group

$24.03

0.03 (0.13%)

WPPGY

WPP PLC

$106.95

1.36 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

AMZN

Amazon.com

$759.36

19.02 (2.57%)

12:49
12/06/16
12/06
12:49
12/06/16
12:49
Periodicals
Amazon sued by Snuggie maker, among others, Reuters says »

Allstar Marketing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$93.49

0.145 (0.16%)

12:45
12/06/16
12/06
12:45
12/06/16
12:45
Hot Stocks
Time Warner CEO Bewkes says HBO subscriber growth not hitting 1M wall »

Time Warner CEO Jeff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SEAS

SeaWorld

$18.00

-0.12 (-0.66%)

12:45
12/06/16
12/06
12:45
12/06/16
12:45
Periodicals
SeaWorld to lay off 320 employees, WSJ says »

SeaWorld said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCS

Barclays

$11.56

0.59 (5.38%)

12:45
12/06/16
12/06
12:45
12/06/16
12:45
Options
Barclays call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPPGY

WPP PLC

$106.95

1.36 (1.29%)

, OMC

Omnicom

$87.06

1.01 (1.17%)

12:43
12/06/16
12/06
12:43
12/06/16
12:43
Periodicals
Breaking Periodicals news story on WPP PLC, Omnicom »

DOJ probing advertising…

WPPGY

WPP PLC

$106.95

1.36 (1.29%)

OMC

Omnicom

$87.06

1.01 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

TWTR

Twitter

12:37
12/06/16
12/06
12:37
12/06/16
12:37
Hot Stocks
Canaccord analysis suggests Twitter could beat Q4 usage forecasts »

Research firm Canaccord…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$84.17

-0.26 (-0.31%)

12:34
12/06/16
12/06
12:34
12/06/16
12:34
Earnings
Schlumberger sees Q4 revenue flat sequentially »

Sees Q4 pretax operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 20

    Jan

NVDA

NVIDIA

$91.88

3.43 (3.88%)

12:34
12/06/16
12/06
12:34
12/06/16
12:34
Options
Sweep buyer of short dated NVDA Calls (Wkly) »

Sweep buyer of short…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$53.48

0.13 (0.24%)

12:32
12/06/16
12/06
12:32
12/06/16
12:32
Hot Stocks
Molina says all eligible health plans increased or maintained CMS star scores »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$93.59

0.25 (0.27%)

, T

AT&T

$39.16

0.525 (1.36%)

12:31
12/06/16
12/06
12:31
12/06/16
12:31
Hot Stocks
Time Warner CEO thinks AT&T deal to be done by end of 2017, if not sooner »

Time Warner (TWX)…

TWX

Time Warner

$93.59

0.25 (0.27%)

T

AT&T

$39.16

0.525 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

HIL

Hill International

$3.85

-0.05 (-1.28%)

12:31
12/06/16
12/06
12:31
12/06/16
12:31
Hot Stocks
Hill International named project manager for Al Wa'ab City development in Qatar »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$55.06

0.71 (1.31%)

12:25
12/06/16
12/06
12:25
12/06/16
12:25
Periodicals
Wells CEO says rates rise will hit bank's short term profit, Reuters reports »

Wells Fargo CEO Tim Sloan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

  • 07

    Dec

BA

Boeing

$151.35

-0.8103 (-0.53%)

, CMG

Chipotle

$367.50

-28.77 (-7.26%)

12:23
12/06/16
12/06
12:23
12/06/16
12:23
General news
On The Fly: Top stock stories at midday »

Stocks began the session…

BA

Boeing

$151.35

-0.8103 (-0.53%)

CMG

Chipotle

$367.50

-28.77 (-7.26%)

VZ

Verizon

$50.34

0.5901 (1.19%)

EQIX

Equinix

$332.08

1.4 (0.42%)

ROP

Roper Technologies

$182.38

0.74 (0.41%)

PROJ

Taken private

TXMD

TherapeuticsMD

$6.58

0.41 (6.65%)

FRAN

Francesca's

$15.54

-0.09 (-0.58%)

BOBE

Bob Evans

$46.77

1.05 (2.30%)

SNCR

Synchronoss

$49.00

1.81 (3.84%)

IL

Intralinks

$13.10

1.834 (16.27%)

RCII

Rent-A-Center

$11.91

0.38 (3.30%)

MIK

Michaels

$24.31

0.34 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 09

    Jan

  • 24

    Jan

DGII

Digi International

$13.65

0.1 (0.74%)

, BDC

Belden

$76.34

1.35 (1.80%)

12:23
12/06/16
12/06
12:23
12/06/16
12:23
Hot Stocks
Digi: No basis for Belden talks as letter reiterates same proposal »

Digi International (DGII)…

DGII

Digi International

$13.65

0.1 (0.74%)

BDC

Belden

$76.34

1.35 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCAR

PACCAR

$65.41

2.31 (3.66%)

12:23
12/06/16
12/06
12:23
12/06/16
12:23
Hot Stocks
PACCAR announces 60c per share extra cash dividend »

PACCAR's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVP

Retractable Technologies

$1.20

-0.04 (-3.23%)

, BDX

Becton Dickinson

$163.69

-0.7206 (-0.44%)

12:21
12/06/16
12/06
12:21
12/06/16
12:21
Hot Stocks
Retractable Technologies says Court of Appeals overturned $340M award from BD »

On Friday, December 2,…

RVP

Retractable Technologies

$1.20

-0.04 (-3.23%)

BDX

Becton Dickinson

$163.69

-0.7206 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$32.54

0.415 (1.29%)

12:20
12/06/16
12/06
12:20
12/06/16
12:20
Options
Notable options strategies in the iShares Brazil Fund »

Notable options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
12/06/16
12/06
12:16
12/06/16
12:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:16
12/06/16
12/06
12:16
12/06/16
12:16
Technical Analysis
NASDAQ market internals summary »

Volume is light for this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEF

Telefonica

$8.38

0.1 (1.21%)

12:15
12/06/16
12/06
12:15
12/06/16
12:15
Initiation
Telefonica initiated  »

Telefonica initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYNO

Cynosure

$44.65

0.3 (0.68%)

12:15
12/06/16
12/06
12:15
12/06/16
12:15
Conference/Events
Cynosure management to meet with Maxim »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

CRTO

Criteo

$39.33

0.65 (1.68%)

12:13
12/06/16
12/06
12:13
12/06/16
12:13
Hot Stocks
Criteo rebounds after responding to blogger's claims »

Shares of ad tech company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

BDRBF

Bombardier

$1.42

0.0199 (1.42%)

, DAL

Delta Air Lines

$48.55

0.73 (1.53%)

12:10
12/06/16
12/06
12:10
12/06/16
12:10
Periodicals
Bombardier expects to win big CSeries order in 2017, Reuters reports »

Bombardier (BDRBF) senior…

BDRBF

Bombardier

$1.42

0.0199 (1.42%)

DAL

Delta Air Lines

$48.55

0.73 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.